APOE and atherosclerosis: Moreover, interventions using the ferroptosis inhibitor ferrostatin-1 (Fer-1) or targeting FABP3 can alleviate PGPC-induced ferroptosis in ECs, improve endothelial function and mitigate atherosclerosis in ApoE−/− mice (Chen S. et al., 2024).